A drug with the SMILES COc1ccc(C2(C)NC(=O)N(CC(=O)Nc3ccc(Br)c(C)c3)C2=O)cc1OC has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 2.171%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1ccc(C2(C)NC(=O)N(CC(=O)Nc3ccc(Br)c(C)c3)C2=O)cc1OC
COc1ccc(C2(C)NC(=O)N(CC(=O)Nc3ccc(Br)c(C)c3)C2=O)cc1OC
N-(4-bromo-3-methylphenyl)-2-[4-(3,4-dimethoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetamide